OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	77
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	53
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	47
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	38
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis	35
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	31
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	31
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series	27
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	26
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial	26
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	24
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	21
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	19
Virtual reality interventions in the assessment and treatment of alcohol use disorder - a systematic scoping review on methodology	19
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	19
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	18
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	18
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	17
Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities	17
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	16
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	16
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	15
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024	15
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	15
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham	14

Adapting the Grog survey app for alcohol screening and feedback in aboriginal and Torres Strait Islander health services: a mixed methods study protocol	13
Proceedings of the 18th Annual Conference of INEBRIA	13
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study	12
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	12
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda	12
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical	12
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps	12
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods	12
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits	12
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder	11
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches	11
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study	11
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	11
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa	11
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program	11
A systematic review of substance use screening in outpatient behavioral health settings	10
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 2023	10
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders	9
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	9
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics	9
Patient experiences of buprenorphine dispensing from a mobile medical unit	9
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	9
Substance use disorder bridge clinics: models, evidence, and future directions	9
“It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management	9
Automated Reinforcement Management System (ARMS): focused phase I provider feedback	9
The development and initial validation of the Russian version of the BASIS-24	8
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol	8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	8
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	8
Rethinking trazodone for insomnia in alcohol use disorder	8
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	8
A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail	8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	8
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	7
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States	7
Attitudes and training related to substance use in pediatric emergency departments	7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	7
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	7
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	7
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	7
Rural providers’ attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest	7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	7
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	7
Comparison of heroin and fentanyl use in US nationally representative surveys	7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	7

Proceedings of the 17th Annual International INEBRIA Conference	7
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	6
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review	6
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	6
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	6
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population	6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single	6
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare	6
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	6